Role of PKC, tyrosine kinases, and Rho kinase in α-adrenoreceptor-mediated PASM contraction

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 283, Issue 5 27-5, 2002, Pages

  Damron, Derek S ^a   Kanaya, Noriaki ^a   Homma, Yasuyuki ^a   Kim, Si Oh ^a   Murray, Paul A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Intracellular calcium ion; Myofilament calcium ion sensitivity; Phenylephrine; Protein kinase C; Pulmonary artery smooth muscle; Vascular smooth muscle

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; INOSITOL 1,4,5 TRISPHOSPHATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RHO KINASE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SARCOPLASMIC RETICULUM; SENSITIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION;

EID: 0036838286     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00345.2001     Document Type: Article

References (53)

1. Aburto T, Jinsi A, and Deth RC. Involvement of protein kinase C activation in alpha 2-adrenoreceptor-mediated contractions of rabbit saphenous vein. Eur J Pharmacol 277: 35-44, 1995.
2. Ascher-Landsberg J, Saunders T, Elovitz M, and Phillippe M. The effects of 2-aminoethoxydiphenyl borate, a novel inositol 1,4,5-trisphosphate receptor modulator on myometrial contractions. Biochem Biophys Res Commun 264: 979-982, 1999.
3. Carmichael JD, Winder SJ, Walsh MP, and Kargacin GJ. Calponin and smooth muscle regulation. Can J Physiol Pharmacol 72: 1415-1419, 1994.
4. Damron DS, Nadim HS, Hong SJ, Darvish A, and Murray PA. Intracellular translocation of protein kinase C isoforms in canine pulmonary artery smooth muscle cells by angiotensin II. Am J Physiol Lung Cell Mol Physiol 274: L278-L288, 1998.
5. De Witt BJ, Kaye AD, Ibrahim IN, Bivalacqua TJ, D'Souza FM, Banister RE, Arif AS, and Nossaman BD. Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed. Am J Physiol Lung Cell Mol Physiol 280: L50-L57, 2001.
6. Di Salvo J, Nelson SR, and Kaplan N. Protein tyrosine phosphorylation in smooth muscle: A potential coupling mechanism between receptor activation and intracellular calcium. Proc Soc Exp Biol Med 214: 285-301, 1997.
7. DiSalvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, and Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 190: 968-974, 1993.
8. 2+ entry and tyrosine kinase activation in canine pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 278: Ll18-L130, 2000.
9. 2+ influx: How many mechanisms for how many channels? Trends Pharmacol Sci 15: 77-83, 1994.
10. 2+ sensitization of rabbit smooth muscle. J Physiol 500: 95-109, 1997.
11. Haller H, Smallwood JI, and Rasmussen H. Protein kinase C translocation in intact vascular smooth muscle strips. Biochem J 270: 375-381, 1990.
12. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflügers Arch 417: 21-28, 1990.
13. 2+-independent contraction in vascular smooth muscle. Am J Physiol Cell Physiol 271: C589-C594, 1996.
14. Horowitz A, Menice CB, LaPorte R, and Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev 76: 967-1003, 1996.
15. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, and Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57: 976-983, 2000.
16. 2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol 280: L1218-L1224, 2001.
17. 2+ re]ease in hypoxic vasoconstriction of canine pulmonary artery. Br J Pharmacol 122: 21-30, 1997.
18. Janssen LJ, Lu-Chao H, and Netherton S. Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase. Am J Physiol Lung Cell Mol Physiol 280: L666-L674, 2001.
19. Jin N, Siddiqui RA, English D, and Rhoades RA. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol Heart Circ Physiol 271: H1348-H1355, 1996.
20. Kaneko T, Amano M, Maeda A, Goto H, Takahashi K, Ito M, and Kaibuchi K. Identification of calponin as a novel substrate of Rho-kinase. Biochem Biophys Res Commun 273: 110-116, 2000.
21. 8]-vasopressin-activated increases in protein tyrosine phosphorylation and cellular calcium in A7r5 aortic smooth muscle cells. Arch Biochem Biophys 326: 271-280, 1996.
22. Kaye AD, Nossaman BD, Ibrahim IN, Feng CJ, and Kadowitz PJ. Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat. Am J Physiol Lung Cell Mol Physiol 268: L532-L538, 1995.
23. Krampetz IK and Rhoades RA. Intracellular pH: Effect on pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 260: L516-L521, 1991.
24. Kusaka M and Sperelakis N. Inhibition of L-type calcium current by genistein, a tyrosine kinase inhibitor, in pregnant rat myometrial cells. Biochim Biophys Acta 1240: 196-200, 1995.
25. α2A-adrenoreceptor subtypes stimulate voltage-operated L-type calcium channels in rat portal vein myocytes. J Biol Chem 269: 29546-29552, 1994
26. Levitzki A. Tyrphostins-potential antiproliferative agents and novel molecular tools. Biochem Pharmacol 40: 913-918, 1990.
27. Li L, Eto M, Lee MR, Morita F, Yazawa M, and Kitazawa T. Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J Physiol 508: 871-881, 1998.
28. Litten RZ, Suba EA, and Roth BL. Effects of a phorbol ester on rat aortic contraction and calcium influx in the presence and absence of BAY K 8644. Eur J Pharmacol 144: 185-191, 1987.
29. Liu H and Sperelakis N. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein. Can J Physiol Pharmacol 75: 1063-1068, 1997.
30. 2+ handling of human small arteries. Am J Physiol Heart Circ Physiol 279: H1228-H1238, 2000.
31. Masuda H, Tanaka K, Takagi M, Ohgami K, Sakamaki T, Shibata N, and Takahashi K. Molecular cloning and characterization of human non-smooth muscle calponin. J Biochem (Tokyo) 120: 415-424, 1996.
32. Meacci E, Donati C, Cencetti F, Romiti E, and Bruni P. Permissive role of protein kinase C alpha but not protein kinase C delta in sphingosine 1-phosphate-induced Rho A activation in C2C12 myoblasts. FEBS Lett 482: 97-101, 2000.
33. Menice CB, Hulvershorn J, Adam LP, Wang CA, and Morgan KG. Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J Biol Chem 272: 25157-25161, 1997.
34. Muthalif MM, Parmentier JH, Benter IF, Karzoun N, Ahmed A, Khandekar Z, Adl MZ, Bourgoin S, and Malik KU. Ras/mitogen-activated protein kinase mediates norepinephrine-induced phospholipase D activation in rabbit aortic smooth muscle cells by a phosphorylation-dependent mechanism. J Pharmacol Exp Ther 293: 268-274, 2000.
35. Nelson MT, Patlak JB, Worley JF, and Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol Cell Physiol 259: C3-C18, 1990.
36. 2+. Circ Res 88: 1283-1290, 2001.
37. Ogawa K, Tanaka S, and Murray PA. Propofol potentiates phenylephrine-induced contraction via cyclooxygenase inhibition in pulmonary artery smooth muscle. Anesthesiology 94: 833-839, 2001.
38. Parsons SJ, Sumner MJ, and Garland CJ. Phospholipase A2 and protein kinase C contribute to myofilament sensitization to 5-HT in the rabbit mesenteric artery. J Physiol 491: 447-453, 1996.
39. Pfitzer G and Arner A. Involvement of small GTPases in the regulation of smooth muscle contraction. Acta Physiol Scand 164:449-456, 1998
40. 2+]-dependent myosin phosphorylation in phorbol diester stimulated smooth muscle contraction. Am J Physiol Cell Physiol 255: C719-C723, 1988.
41. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, and Takuwa Y. Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol Cell Physiol 281: C571-C578, 2001.
42. Savineau JP, Gonzalez De La Fuente P, and Marthan R. Effect of modulators of tyrosine kinase activity on agonist-induced contraction in the rat pulmonary vascular smooth muscle. Pulm Pharmacol 9: 189-195, 1996.
43. Semenchuk LA and Di Salvo J. Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS Lett 370: 127-130, 1995.
44. Slater SJ, Seiz JL, Stagliano BA, and Stubbs CD. Interaction of protein kinase C isozymes with Rho GTPases. Biochemistry 40: 4437-4445, 2001.
45. Somlyo AP and Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
46. Somlyo AP and Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2001.
47. 2+ oscillations in isolated rat aorta: Role of protein kinase C. J Smooth Muscle Res 36: 205-218, 2000.
48. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
49. 2+]i smooth muscle. Annu Rev Physiol 51: 315-329, 1989.
50. Walsh MP, Andrea JE, Allen BG, Clement-Chomienne O, Collins EM, and Morgan KG. Smooth muscle protein kinase C. Can J Physiol Pharmacol 72: 1392-1399, 1994.
51. Wijetunge S, Aalkjaer C, Schachter M, and Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 189:1620-1623, 1992.
52. c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 217: 1039-1044, 1995.
53. 2+ mobilization in smooth muscle cells by protein kinase C. Am J Physiol Cell Physiol 266: C1560-C1567, 1994.